NCT05392673View on ClinicalTrials.gov

Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure.

NACompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Chronic-on-acute Liver Failure
Interventions
OTHER

KM-8800 plasma exchange device (Kuraray, Tokyo, Japan)

Artificial liver scavenges inflammatory factors.

Trial Locations (1)

Unknown

Xiangya Hospital of Central South University, Changsha

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER

NCT05392673 - Efficacy and Economic Evaluation of Nonbiological Artificial Liver Therapy in Acute-on-chronic Hepatitis B Liver Failure. | Biotech Hunter | Biotech Hunter